NYSE:ABBVBiotechs
AbbVie (ABBV) Q1 2026 Margin Compression Tests Bullish High P/E Narrative
AbbVie Q1 2026 earnings at a glance
AbbVie (ABBV) has opened 2026 with Q1 results showing revenue of US$15.0b and basic EPS of US$0.39, alongside net income of US$695m. Over the past year, the company has seen revenue move from US$56.3b on a trailing twelve month basis in Q4 2024 to US$62.8b by Q1 2026. Over the same period, trailing basic EPS shifted from US$2.40 to US$2.03 as net income moved from US$4.2b to US$3.6b. With a trailing net profit margin of 5.7% that reflects a large one off...